These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17376783

  • 1. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH, Belyakov IM, Isakov DV, Margulies DH, Berzofsky JA.
    Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
    [Abstract] [Full Text] [Related]

  • 2. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
    Chung DH, Belyakov IM, Derby MA, Wang J, Boyd LF, Berzofsky JA, Margulies DH.
    J Immunol; 2001 Jul 15; 167(2):699-707. PubMed ID: 11441073
    [Abstract] [Full Text] [Related]

  • 3. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
    Nakagawa Y, Shimizu M, Norose Y, Takahashi M, Takahashi H.
    Int Immunol; 2013 Jan 15; 25(1):11-24. PubMed ID: 22945875
    [Abstract] [Full Text] [Related]

  • 4. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H, Wakabayashi A, Shimizu M, Kaneko H, Norose Y, Nakagawa Y, Wang J, Kumagai Y, Margulies DH, Takahashi H.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):356-63. PubMed ID: 15020225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J.
    J Immunol; 1998 Feb 15; 160(4):1555-64. PubMed ID: 9469410
    [Abstract] [Full Text] [Related]

  • 7. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
    Belyakov IM, Kozlowski S, Mage M, Ahlers JD, Boyd LF, Margulies DH, Berzofsky JA.
    Int Immunol; 2007 Dec 15; 19(12):1413-20. PubMed ID: 17981793
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN, Jenkinson SR, Williams NA, Morgan DJ.
    Cancer Res; 2008 Apr 15; 68(8):2993-3000. PubMed ID: 18413769
    [Abstract] [Full Text] [Related]

  • 18. Culture filtrate specific H-2(b) restricted CD8+ T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides.
    Denis O, Stroobant V, Colau D, D'Souza S, Huygen K.
    Immunol Lett; 2002 Apr 22; 81(2):115-24. PubMed ID: 11852116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
    Gold MC, Munks MW, Wagner M, Koszinowski UH, Hill AB, Fling SP.
    J Immunol; 2002 Jul 01; 169(1):359-65. PubMed ID: 12077265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.